Back to User profile » Mr Todor Totev
Papers published by Mr Todor Totev:
Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom
Heinze A, Afridi SK, Totev TI, Krasenbaum LJ, Terasawa E, Akcicek H, Hipp J, Dhiraj D, Sun R, Yim E, Yilma B, Driessen MT
Therapeutics and Clinical Risk Management 2026, 22:529550
Published Date: 14 January 2026
Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
Zhdanava M, Starr HL, Totev TI, Lefebvre P, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:2003-2019
Published Date: 7 September 2022
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
Zhdanava M, Starr HL, Lefebvre P, Totev TI, Shah A, Sheng K, Pilon D
Neuropsychiatric Disease and Treatment 2022, 18:1479-1493
Published Date: 22 July 2022
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
Metz DC, Liu E, Joish VN, Huynh L, Totev TI, Duh MS, Seth K, Giacalone S, Lapuerta P, Morse MA
Cancer Management and Research 2020, 12:9713-9719
Published Date: 7 October 2020